Cargando…
A Phase I, multicenter, open-label trial to evaluate the safety of talimogene laherparepvec (T-VEC) injected into liver tumors
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645260/ http://dx.doi.org/10.1186/2051-1426-3-S2-P180 |
| _version_ | 1782400794840006656 |
|---|---|
| author | Hecht, J Randolph Raman, Steven Sze, Daniel Y Lockhart, A Craig Moss, Rebecca A Liu, Kate Chou, Jeffrey Reid, Tony |
| author_facet | Hecht, J Randolph Raman, Steven Sze, Daniel Y Lockhart, A Craig Moss, Rebecca A Liu, Kate Chou, Jeffrey Reid, Tony |
| author_sort | Hecht, J Randolph |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4645260 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46452602015-11-20 A Phase I, multicenter, open-label trial to evaluate the safety of talimogene laherparepvec (T-VEC) injected into liver tumors Hecht, J Randolph Raman, Steven Sze, Daniel Y Lockhart, A Craig Moss, Rebecca A Liu, Kate Chou, Jeffrey Reid, Tony J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4645260/ http://dx.doi.org/10.1186/2051-1426-3-S2-P180 Text en Copyright © 2015 Hecht et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Hecht, J Randolph Raman, Steven Sze, Daniel Y Lockhart, A Craig Moss, Rebecca A Liu, Kate Chou, Jeffrey Reid, Tony A Phase I, multicenter, open-label trial to evaluate the safety of talimogene laherparepvec (T-VEC) injected into liver tumors |
| title | A Phase I, multicenter, open-label trial to evaluate the safety of talimogene laherparepvec (T-VEC) injected into liver tumors |
| title_full | A Phase I, multicenter, open-label trial to evaluate the safety of talimogene laherparepvec (T-VEC) injected into liver tumors |
| title_fullStr | A Phase I, multicenter, open-label trial to evaluate the safety of talimogene laherparepvec (T-VEC) injected into liver tumors |
| title_full_unstemmed | A Phase I, multicenter, open-label trial to evaluate the safety of talimogene laherparepvec (T-VEC) injected into liver tumors |
| title_short | A Phase I, multicenter, open-label trial to evaluate the safety of talimogene laherparepvec (T-VEC) injected into liver tumors |
| title_sort | phase i, multicenter, open-label trial to evaluate the safety of talimogene laherparepvec (t-vec) injected into liver tumors |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645260/ http://dx.doi.org/10.1186/2051-1426-3-S2-P180 |
| work_keys_str_mv | AT hechtjrandolph aphaseimulticenteropenlabeltrialtoevaluatethesafetyoftalimogenelaherparepvectvecinjectedintolivertumors AT ramansteven aphaseimulticenteropenlabeltrialtoevaluatethesafetyoftalimogenelaherparepvectvecinjectedintolivertumors AT szedaniely aphaseimulticenteropenlabeltrialtoevaluatethesafetyoftalimogenelaherparepvectvecinjectedintolivertumors AT lockhartacraig aphaseimulticenteropenlabeltrialtoevaluatethesafetyoftalimogenelaherparepvectvecinjectedintolivertumors AT mossrebeccaa aphaseimulticenteropenlabeltrialtoevaluatethesafetyoftalimogenelaherparepvectvecinjectedintolivertumors AT liukate aphaseimulticenteropenlabeltrialtoevaluatethesafetyoftalimogenelaherparepvectvecinjectedintolivertumors AT choujeffrey aphaseimulticenteropenlabeltrialtoevaluatethesafetyoftalimogenelaherparepvectvecinjectedintolivertumors AT reidtony aphaseimulticenteropenlabeltrialtoevaluatethesafetyoftalimogenelaherparepvectvecinjectedintolivertumors AT hechtjrandolph phaseimulticenteropenlabeltrialtoevaluatethesafetyoftalimogenelaherparepvectvecinjectedintolivertumors AT ramansteven phaseimulticenteropenlabeltrialtoevaluatethesafetyoftalimogenelaherparepvectvecinjectedintolivertumors AT szedaniely phaseimulticenteropenlabeltrialtoevaluatethesafetyoftalimogenelaherparepvectvecinjectedintolivertumors AT lockhartacraig phaseimulticenteropenlabeltrialtoevaluatethesafetyoftalimogenelaherparepvectvecinjectedintolivertumors AT mossrebeccaa phaseimulticenteropenlabeltrialtoevaluatethesafetyoftalimogenelaherparepvectvecinjectedintolivertumors AT liukate phaseimulticenteropenlabeltrialtoevaluatethesafetyoftalimogenelaherparepvectvecinjectedintolivertumors AT choujeffrey phaseimulticenteropenlabeltrialtoevaluatethesafetyoftalimogenelaherparepvectvecinjectedintolivertumors AT reidtony phaseimulticenteropenlabeltrialtoevaluatethesafetyoftalimogenelaherparepvectvecinjectedintolivertumors |